Prot #J2P‐MC‐LXBD: A Phase 2, Randomized, Double‐Blind, Placebo Controlled, Dose‐Ranging Study to Evaluate LY3556050 in Adult Participants with Diabetic Peripheral Neuropathic Pain

Project: Research project

Project Details

StatusActive
Effective start/end date10/5/2310/5/26

Funding

  • Lilly USA, LLC (Prot #J2P-MC-LXBD WAN 3)